NCT05167318

Brief Summary

Premature very low birth weight (VLBW) infants are susceptible to complications related to infrequent and non-standardized oral care. Although the benefits of frequent standardized oral care are known to reduce oral dybiosis (increased level of potentially pathogenic bacteria) and its associated complications in critically ill adults leading to established evidence-based guidelines, no such information exists for VLBW infants. The proposed study will prospectively follow 40 VLBW infants for 4 weeks following birth. Infants will be randomized into 1 of 2 groups. Standardized oral care will be performed every 3-4 hours (Group 1) and every 12 hours (Group 2). Aim 1 will evaluate the feasibility of frequent standardized oral care, Aim 2 will compare the oral microbiome between groups, and Aim 3 will compare respiratory outcomes including the incidence of ventilator associated pneumonia, bronchopulmonary dysplasia and need for respiratory support between infants receiving standardized oral care every 3-4 hours and every 12 hours. Issues related to recruitment, retention, randomization, acceptance by nursing staff, and treatment fidelity will be examined. Saliva samples will be obtained weekly and analyzed using 16S sequencing, respiratory cultures will be obtained weekly on ventilated infants, and respiratory outcomes will be collected from the medical records.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 22, 2021

Completed
24 days until next milestone

Study Start

First participant enrolled

January 15, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2023

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2026

Completed
Last Updated

December 11, 2025

Status Verified

December 1, 2025

Enrollment Period

1.7 years

First QC Date

November 18, 2021

Last Update Submit

December 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Type of of bacterial in the oral cavity

    microbial analysis of the oral microbiome

    weekly for 4 weeks

Secondary Outcomes (2)

  • Days of respiratory support

    Up to 100 days

  • Incidence of chronic lung disease

    Up to 100 days

Study Arms (2)

every 3-4 hour oral care

EXPERIMENTAL

Infants will receive standardized oral care every 3-4 hours for 4 weeks

Other: frequent standardized oral care

every 12 hour oral care

NO INTERVENTION

Infants will receive standardized oral care every 12 hours for 4 weeks

Interventions

Standardized oral care will be provided every 3-4 hours

every 3-4 hour oral care

Eligibility Criteria

Age12 Hours - 72 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gestational age \< 32 weeks
  • birth weight \< 1500 grams
  • mother is English speaking
  • mother is \> 18 years of age.

You may not qualify if:

  • Congenital anomalies of the face, lungs, or gastrointestinal system
  • not expected to survive

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Florida

Gainesville, Florida, 32610, United States

Location

MeSH Terms

Conditions

Communicable DiseasesPneumonia, Ventilator-Associated

Condition Hierarchy (Ancestors)

InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHealthcare-Associated PneumoniaCross InfectionPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesIatrogenic Disease

Study Officials

  • Leslie Parker

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2021

First Posted

December 22, 2021

Study Start

January 15, 2022

Primary Completion

October 2, 2023

Study Completion

March 30, 2026

Last Updated

December 11, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations